Downing LLP is pleased to announce that it has been selected as a Finalist in the Investor category as part of the upcoming LaingBuisson Awards 2020.
Now in its 15th year, the LaingBuisson Awards celebrate businesses that set new standards of excellence throughout the healthcare sector.
Downing is actively investing right across the healthcare spectrum, including elderly residential healthcare, specialist care, specialist education, retirement living, health services, medical devices, imaging and diagnostic services, biotechnology and health & wellbeing platforms. We are recognised as a leading player in UK Healthcare by multiple parties and are also finalists in the Investor category at the 2020 HealthInvestor Awards.
The final winner will be announced at an awards ceremony held in November 2020.
Commenting on Downing’s LaingBuisson finalist nomination, Mark Gross, Partner at Downing LLP, said: "Growing companies in the healthcare sector are typically underserved by other investors and we see it as our role to help fill this funding gap by providing both debt and equity to these innovative and highly motivated businesses.
"Our nomination is also a reflection of the inspirational management teams from the healthcare businesses we support, and we are extremely proud to work alongside them as they develop and grow."